Felice Bombaci

Rome, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Unmet needs and quality of life burden in chronic myeloid leukemia: results from a nationwide Italian real-world survey.

Unmet needs and quality of life burden in chronic myeloid leukemia: results from a nationwide Italian real-world survey.

Journal: Frontiers in oncology
Published: April 03, 2026

Favorable tolerability of asciminib versus ATP-competitive tyrosine kinase inhibitors in the ASC4FIRST study of newly diagnosed patients with chronic-phase chronic myeloid leukemia.

Favorable tolerability of asciminib versus ATP-competitive tyrosine kinase inhibitors in the ASC4FIRST study of newly diagnosed patients with chronic-phase chronic myeloid leukemia.

Journal: Haematologica
Published: October 31, 2025

A charter for improving care for people living with chronic lymphocytic leukemia: six principles for excellence.

A charter for improving care for people living with chronic lymphocytic leukemia: six principles for excellence.

Journal: Leukemia & lymphoma
Published: July 12, 2025

Asciminib demonstrates superior efficacy and safety in newly diagnosed chronic myeloid leukemia in the ASC4FIRST trial.

Asciminib demonstrates superior efficacy and safety in newly diagnosed chronic myeloid leukemia in the ASC4FIRST trial.

Journal: Blood
Published: July 01, 2025

Asciminib Demonstrates Superior Efficacy and Safety in Newly Diagnosed Chronic Myeloid Leukemia in the ASC4FIRST Trial.

Asciminib Demonstrates Superior Efficacy and Safety in Newly Diagnosed Chronic Myeloid Leukemia in the ASC4FIRST Trial.

Journal: Blood
Published: July 01, 2025

Supporting treatment decision-making for patients with multiple myeloma post-DRd in Italy: a multi-criteria decision framework.

Supporting treatment decision-making for patients with multiple myeloma post-DRd in Italy: a multi-criteria decision framework.

Journal: BMC cancer
Published: April 17, 2025

Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.

Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.

Journal: The New England journal of medicine
Published: May 31, 2024

Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in Italy.

Impact on mental health, disease management, and socioeconomic modifications in hematological patients during the COVID-19 pandemic in Italy.

Journal: Therapeutic advances in hematology
Published: February 11, 2023

Asciminib monotherapy for newly diagnosed chronic myeloid leukemia in chronic phase: the ASC4FIRST phase III trial.

Asciminib monotherapy for newly diagnosed chronic myeloid leukemia in chronic phase: the ASC4FIRST phase III trial.

Journal: Future oncology (London, England)
Published: December 16, 2022

Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab.

Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab.

Journal: Diagnostic and interventional imaging
Published: March 25, 2020

CT features of an uncommon association between coronary-pulmonary fistula and Vieussens' arterial ring.

CT features of an uncommon association between coronary-pulmonary fistula and Vieussens' arterial ring.

Journal: Diagnostic and interventional imaging
Published: March 10, 2020

Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needs.

Treatment-free remission in chronic myeloid leukemia: the patient perspective and areas of unmet needs.

Journal: Leukemia
Published: November 06, 2019
Showing 1-12 of 16

Last Updated: 09/26/2026